OATL 2016: Programme

Please note that timings are provisional and subject to change.
Speaker Conflict of Interest forms are here
Confirmation of accreditation is here
Thursday evening

18:30
Welcome to the event
The Chairpersons

18:35
The Lancet Haematology Lecture:- introduced by Dr Lan-Lan Smith – Editor of the Lancet Haematology
Childhood ALL in the UK: Treatment at the Limits
Consultant Paediatric Haematologist, Sheffield Children’s Hospital, Sheffield, United Kingdom

19:20
High-precision radiotherapy and the integration of modern imaging techniques
Head of the Department of Radiation Oncology, The Technical University of Munich, Munich, Germany
Friday

08:30
Early detection and treatment of cancer of the oesophagus
Honorary Consultant Physician, Addenbrooke’s NHS Trust; Director of Studies for Medical Sciences, Trinity College, Cambridge, University of Cambridge, Cambridge, United Kingdom

09:15
T-cell mediated immunotherapies for Cancer
Director of Medical Oncology at the University of Manchester and Christie Hospital, Manchester, United Kingdom
Break

10:30
Cancer immunotherapy affecting patients with unresectable stage III or stage IV malignant melanoma
Professor of Medicine (Medical Oncology); Co-Director, Yale SPORE in Skin Cancer, Yale School of Medicine, New Haven, CT., USA

11:15
Immunotherapy in bladder cancer: research at the limits
Professor Medical of Oncology & Urology; Professor; Co-Director, Signal Transduction Research Program, Prostate and Urologic Cancer Program, Smilow Cancer Hospital at Yale – New Haven, USA
Lunch

13:00
The Lancet Oncology Lecture:- introduced by Dr Cassandra Coburn – Deputy Editor of the Lancet Oncology
Targeted therapy in Breast Cancer matched to individuals’ genomic alterations
Director, Translational Research Laboratory, Institut Gustave Roussy, Villejuif, France

13:45
Immunotherapy for the treatment of triple-negative breast cancer
Associate Director, Breast Medical Oncology, the University of Chicago, MA., USA
Break

15:00
Image guided therapy of Hepatomas
Chair of the Department of Radiology and Biomedical Imaging & Chief of Radiology and Biomedical Imaging at Yale School of Medicine and Yale-New Haven Hospital, New Haven, CT USA

15:45
Novel Personalised Therapeutic Strategies in Pancreatic Cancer
Regius Chair of Surgery & Director of the Translational Research Centre, Institute of Cancer Sciences, University of Glasgow, Bearsden, United Kingdom
Saturday

09:00
The cellular complexity of nerve regeneration- implications for nerve repair and tumourigenesis
Professor of cell biology, MRC Laboratory for Molecular Cell Biology, University College London, United Kingdom

09:45
Phase 1 trial design
Clinical Professor of Experimental Cancer Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom
Break

11:00
Extracting clues for developing new EGFR inhibitory approaches in cancer
Professor of Pharmacology; Co-director, Cancer Biology Institute, Yale School of Medicine, New Haven, CT., USA

11:45
Using functional genomics to identify genes that modify the tumor cell response to therapy
Director of the UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA
Lunch

13:30
Isoforms of PI 3-kinase in cancer
Professor of Cell Signalling, Research Department of Oncology, UCL Cancer Institute, London, United Kingdom, UK

14:15
Alternating electric fields and other advances for treatment of glioma
Chair & Director, Department of Oncology, University Hospital Zurich, Zurich, Switzerland

Oncology at the Limits is supported by educational grants from the Pharmaceutical Industry
A list of 2016 supporters is at http://www.atthelimits.org/supporters-2016/